BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 6573085)

  • 21. [Urea in the intrauterine space of IUD users (author's transl)].
    Nesit V; Garcic A
    Cas Lek Cesk; 1977 Nov; 116(45):1401-3. PubMed ID: 603886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytologic studies after insertion of intrauterine contraceptive devices (IUD) (author's transl)].
    Prinz W; Noack J; Kraus H; Schuhmann RA
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):194-8. PubMed ID: 7215760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endometrial cytology and copper containing intrauterine devices].
    Herting W; Tauber PF
    Fortschr Med; 1978 Feb; 96(7):311-4. PubMed ID: 304829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IUD-induced uterine bleeding.
    El-badrawi HH; Hafez ES
    Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms behind intrauterine device-induced luteal persistence in mares.
    Rivera Del Alamo MM; Reilas T; Kindahl H; Katila T
    Anim Reprod Sci; 2008 Aug; 107(1-2):94-106. PubMed ID: 17643876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible role of mast cells in the mechanism of action of intrauterine contraceptive devices.
    Tursi A; Mastrorilli A; Ribatti D; Loiudice L; Contino R; Claudatus J
    Am J Obstet Gynecol; 1984 Apr; 148(8):1064-6. PubMed ID: 6711640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of intrauterine progesterone on the DNA-content in isolated human endometrial cells.
    Johannisson E; Langren BM; Hagenfeldt K
    Acta Cytol; 1977; 21(3):441-6. PubMed ID: 268127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine contraceptive devices and their biological effect.
    Sagiroglu N; Sagiroglu E
    Hacettepe Bull Med Surg; 1969 Oct; 2(4):179-214. PubMed ID: 12275348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine response to PGE2 with IUDs: a possible mechanism of action and side effect.
    Toppozada M; Rizk M; Thabet MH; Shaala S
    Contracept Deliv Syst; 1980 Oct; 1(4):349-63. PubMed ID: 12262137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cytology associated with levonorgestrel contraception.
    Misra JS; Engineer AD; Tandon P
    Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronidase activity of human endometrial tissues & uterine fluids.
    Ganguly S; Sarkar D; Sengupta D; Banerjee SK; Ghosh JJ
    Indian J Exp Biol; 1975 Sep; 13(5):497-8. PubMed ID: 1218911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytological complications of IUDs ].
    Saurel J; Marc J; Audebert A; Malgouyat R; Morard JL
    Sem Hop; 1982 Jul; 58(28-29):1703-7. PubMed ID: 6289452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal pH effects caused by OCs and various copper and inert IUDs.
    Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
    Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The cytology of endometrial cavity with retained IUD (author's transl)].
    Zhou SW
    Zhonghua Fu Chan Ke Za Zhi; 1980 Jul; 15(3):165-8. PubMed ID: 7472015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytological changes caused by intrauterine devices].
    Gribaudi G; Alasio L
    Pathologica; 1981; 73(1024):207-16. PubMed ID: 7335396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histological aspects of the endometrium in users of intrauterine devices].
    Carneiro de Moura ML; Botelho M; Madureira R
    Acta Med Port; 1981; 3(1):11-22. PubMed ID: 7304264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.